These findings support the assertion that the beneficial effects of OA for ischemic optic neuropathy are associated with the activation of Nrf2 signaling, promoting M2 microglia polarization and attenuating the ischemia-induced inflammation and demyelination and apoptotic death of RGCs. Here, NFE2L2 is linked to ischemia.